Literature DB >> 10988240

Dystrophin associates with caveolae of rat cardiac myocytes: relationship to dystroglycan.

D D Doyle1, G Goings, J Upshaw-Earley, S K Ambler, A Mondul, H C Palfrey, E Page.   

Abstract

The possibility of an interaction between the cytoskeletal protein dystrophin and cell surface caveolae in the mammalian myocardium was investigated by several techniques. Caveolin (cav)-3-enriched, detergent-insoluble membranes isolated from purified ventricular sarcolemma by density-gradient fractionation were found to contain dystrophin and dystroglycan. Further purification of cav-3-containing membranes by immunoprecipitation using anti-cav-3-coated magnetic beads yielded dystrophin but not always dystroglycan. Electron microscopic analysis of precipitated material revealed caveola-sized vesicular profiles that could be double-labeled with anti-dystrophin and anti-cav-3 antibodies. In contrast, immunoprecipitation of membranes with anti-dystrophin-coated beads yielded both cav-3 and dystroglycan. Electron microscopic analysis of this material showed heterogeneous membrane profiles, some of which could be decorated with anti-cav-3 antibodies. To confirm that dystrophin and cav-3 were closely associated in cardiac myocytes, we verified that dystrophin was also present in immunoprecipitated cav-3-containing membranes from detergent extracts, as well as in sonicated extracts of purified ventricular myocytes. Confocal immunofluorescence microscopy of ventricular and atrial cardiac myocytes showed that the cellular distributions of cav-3 and dystrophin partially overlapped. Immuno-electron micrographs of thin sections of rat atrial myocytes revealed a fraction of dystrophin molecules that are in apparently close apposition to caveolae. These results suggest that a subpopulation of dystrophin molecules interacts with cardiac myocyte caveolae in vivo and that some of the dystrophin is engaged in linking cav-3 with the dystroglycan complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988240     DOI: 10.1161/01.res.87.6.480

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  5 in total

Review 1.  Molecular Pathophysiology of Congenital Long QT Syndrome.

Authors:  M S Bohnen; G Peng; S H Robey; C Terrenoire; V Iyer; K J Sampson; R S Kass
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 2.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin.

Authors:  Hong Wang; Elena Marrosu; Daniel Brayson; Nalinda B Wasala; Eric K Johnson; Charlotte S Scott; Yongping Yue; Kwan-Leong Hau; Aaron J Trask; Stan C Froehner; Marvin E Adams; Liwen Zhang; Dongsheng Duan; Federica Montanaro
Journal:  Hum Mol Genet       Date:  2021-06-26       Impact factor: 6.150

4.  In vivo proteomic mapping through GFP-directed proximity-dependent biotin labelling in zebrafish.

Authors:  Zherui Xiong; Harriet P Lo; Kerrie-Ann McMahon; Nick Martel; Alun Jones; Michelle M Hill; Robert G Parton; Thomas E Hall
Journal:  Elife       Date:  2021-02-16       Impact factor: 8.140

Review 5.  Caveolin-3 and Arrhythmias: Insights into the Molecular Mechanisms.

Authors:  Miaomiao He; Jie Qiu; Yan Wang; Yang Bai; Guangzhi Chen
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.